Pharmaceutical Research

Individual Bioequivalence: Attractive in Principle, Difficult in Practice
pp. 1321-1325(5)
Authors: Endrenyi L.; Amidon G.L.; Midha K.K.; Skelly J.P.

Chitosan and Its Use as a Pharmaceutical Excipient
pp. 1326-1331(6)
Author: Ilium L.

Chitosan-Based Vector/DNA Complexes for Gene Delivery: Biophysical Characteristics and Transfection Ability
pp. 1332-1339(8)
Authors: Erbacher P.; Zou S.; Bettinger T.; Steffan A-M.; Remy J-S.

Target Specific Optimization of Cationic Lipid-Based Systems for Pulmonary Gene Therapy
pp. 1340-1347(8)
Authors: Deshpande D.; Blezinger P.; Pillai R.; Duguid J.; Freimark B.; Rolland A.

Beta Cyclodextrins Enhance Adenoviral-Mediated Gene Delivery to the Intestine
pp. 1348-1355(8)
Authors: Croyle M.A.; Roessler B.J.; Hsu C-P.; Sun R.; Amidon G.L.

Characterization and In Vivo Testing of a Heterogeneous Cationic Lipid-DNA Formulation
pp. 1356-1363(8)
Authors: Smith J.G.; Wedeking T.; Vernachio J.H.; Way H.; Niven R.W.

Liposomes Dispersed Within a Thermosensitive Gel: A New Dosage Form for Ocular Delivery of Oligonucleotides
pp. 1364-1369(6)
Authors: Bochot A.; Fattal E.; Gulik A.; Couarraze G.; Couvreur P.

Prediction of Intestinal Drug Absorption Properties by Three-Dimensional Solubility Parameters
pp. 1370-1375(6)
Author: Breitkreutz J.

Overexpression of Human Intestinal Oligopeptide Transporter in Mammalian Cells via Adenoviral Transduction
pp. 1376-1381(6)
Authors: Hsu C-P.; Hilfinger J.M.; Walter E.; Merkle H.P.; Roessler B.J.; Amidon G.L.

Cellular Uptake Mechanism of Amino Acid Ester Prodrugs in Caco-2/hPEPT1 Cells Overexpressing a Human Peptide Transporter
pp. 1382-1386(5)
Authors: Han H-k.; Oh D-M.; Amidon G.L.

Permeability Characteristics of Tetragastrins Across Intestinal Membranes Using the Caco-2 Monolayer System: Comparison Between Acylation and Application of Protease Inhibitors
pp. 1387-1392(6)
Authors: Fujita T.; Kawahara I.; Quan Y-s.; Hattori K.; Takenaka K.; Muranishi S.; Yamamoto A.

Transport of Proteolytic Enzymes Across Caco-2 Cell Monolayers
pp. 1393-1400(8)
Authors: Bock U.; Kolac C.; Borchard G.; Koch K.; Fuchs R.; Streichhan P.; Lehr C-M.

Hydrophobicity of HIV Protease Inhibitors by Immobilized Artificial Membrane Chromatography: Application and Significance to Drug Transport
pp. 1401-1406(6)
Authors: Stewart B.H.; Chung F.Y.; Tait B.; John C.; Chan O.H.

Mechanisms of Liposomes/Water Partitioning of (p-Methylbenzyl)alkylamines
pp. 1407-1413(7)
Authors: Fruttero R.; Caron G.; Fornatto E.; Boschi D.; Ermondi G.; Gasco A.; Carrupt P-A.; Testa B.

Permeability of Articular Cartilage to Matrix Metalloprotease Inhibitors
pp. 1414-1418(5)
Authors: Peng S.X.; VonBargen E.C.; Bornes D.M.; Pikul S.

Prodrugs of Gestodene for Matrix-Type Transdermal Drug Delivery Systems
pp. 1419-1424(6)
Authors: Lipp R.; Laurent H.; Günther C.; Riedl J.; Esperling P.; Täuber U.

Characterization of Three Crystalline Forms (VIII, XI, and XII) and the Amorphous Form (V) of Delavirdine Mesylate Using 13C CP/MAS NMR
pp. 1425-1433(9)
Author: Gaou P.

Self-Association Properties of Monomeric Insulin Analogs Under Formulation Conditions
pp. 1434-1441(8)
Authors: Richards J.P.; Stickelmeyer M.P.; Flora D.B.; Chance R.E.; Frank B.H.; DeFelippis M.R.

Effect of Gelation on the Chemical Stability and Conformation of Leuprolide
pp. 1442-1448(7)
Authors: Tan M.M.; Corley C.A.; Stevenson C.L.

Degradation Kinetics of Three Gonadorelin Analogues: Developing a Method for Calculating Epimerization Parameters
pp. 1449-1455(7)
Authors: Hoitink M.A.; Beijnen J.H.; Boschma M.U.S.; Bult A.; van der Houwen O.A.G.J.; Wiese G.; Underberg W.J.M.

Chemical Degradation Kinetics of Recombinant Hirudin (HVI) in Aqueous Solution: Effect of pH
pp. 1456-1462(7)
Authors: Gietz U.; Alder R.; Langguth P.; Arvinte T.; Merkle H.P.

Automated Covariate Model Building Within NONMEM
pp. 1463-1468(6)
Authors: Jonsson E.N.; Karlsson M.O.

Correction for Non-Ideal Tracer Pharmacokinetic Disposition by Disposition Decomposition Analysis (DDA)
pp. 1469-1473(5)
Authors: Veng-Pedersen P.; Hong S.S.; Widness J.A.; Schmidt R.L.

Correlation of Plasma Clearance of 54 Extensively Metabolized Drugs Between Humans and Rats: Mean Allometric Coefficient of 0.66
pp. 1474-1479(6)
Authors: Chiou W.L.; Robbie G.; Chung S.M.; Wu T-C.; Ma C.

Enzymatic Degradation of Luteinizing Hormone Releasing Hormone (LHRH)/[D-Ala6]-LHRH in Lung Pneumocytes
pp. 1480-1484(5)
Authors: Yang X.; Rojanasakul Y.; Wang L.; Ma J.Y.C.; Ma J.K.H.

The Roles of Depot Injection Sites and Proximal Lymph Nodes in the Presystemic Absorption of Fluphenazine Decanoate and Fluphenazine: Ex Vivo Experiments in Rats
pp. 1485-1489(5)
Authors: Luo J-p.; Hubbard J.W.; Midha K.K.

Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds
pp. 1490-1494(5)
Authors: Yazdanian M.; Glynn S.L.; Wright J.L.; Hawi A.

Cellular Uptake Study of Biodegradable Nanoparticles in Vascular Smooth Muscle Cells
pp. 1495-1498(4)
Authors: Suh H.; Jeong B.; Liu F.; Kim S.W.

Effect of Neutral Endopeptidase Inhibition on the Natriuresis and Renal Clearance of Atrial Natriuretic Peptide in Perfused Rat Kidney
pp. 1499-1502(4)
Authors: Yamaguchi M.; Hashimoto Y.; Itoh H.; Nakao K.; Inui K-i.